Search Results - "Kniajeskaia, N P"

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma by Zyryanov, S K, Avdeev, S N, Ivanov, D A, Zhuravleva, M V, Kniajeskaia, N P, Matveev, N V, Nenasheva, N A, Fomina, D S, Frolov, M I

“…During last few years, the approaches to the management of patients with severe asthma have been revised. Monoclonal antibodies (MABs), inhibitors of…”
Get full text

Omalizumab and modification of bronchial asthma natural course by Kniajeskaia, N. P., Anaev, E. H., Belevskiy, A. S., Kameleva, A. A., Safoshkina, E. V., Kirichenko, N. D.

“…Clinical and molecular heterogeneity of bronchial asthma has been documented in recent years. The search for novel solutions to enhance efficient patient…”
Get full text

Targeted therapy in bronchial asthma. Benralizumab: focus on patients using systemic glucocorticosteroids by Kniajeskaia, N. P., Anaev, E. Kh, Kameleva, A. A., Safoshkina, E. V., Kirichenko, N. D.

“…A severe course of bronchial asthma develops in 5–20% of patients with bronchial asthma. The use of key disease-modifying agents for the treatment of severe…”
Get full text

Omalizumab as the first drug of genetically engineered biological therapy: New expectations and relevance of use in bronchial asthma by Kniajeskaia, N. P., Safoshkina, E. V., Kameleva, A. A., Belevsky, A. S., Anaev, E. Kh

“…Recognition of the fact that asthma is a complex, multifactorial disorder has led to a more serious focus on the patient and on those disorders of his…”
Get full text

Dupilumab in complex therapy for chronic rhinosinusitis with nasal polyps and asthma by Sivokhin, D. A., Shchennikova, E. S., Royuk, V. V., Kniajeskaia, N. P.

“…Chronic Rhinosinusitis with Nasal Polyps (CRwNP) caused by T2 inflammation has a complex pathogenesis, for which treatment options include medical therapy…”
Get full text